MANJUSHA GAGLANI to Respiratory Syncytial Virus Vaccines
This is a "connection" page, showing publications MANJUSHA GAGLANI has written about Respiratory Syncytial Virus Vaccines.
Connection Strength
0.446
-
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons. JAMA. 2025 Oct 28; 334(16):1442-1451.
Score: 0.228
-
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination. JAMA Netw Open. 2025 04 01; 8(4):e252841.
Score: 0.219